This feature has been used to detect tumor sites with SST PET with computed tomography (PET/CT) and to selectively treat SST-expressing lesions with peptide receptor radioligand therapy (PRRT) with [6]Y- or [177]Lu-labeled somatostatin analogs [1]. This evidence concerns the gene SST and neoplasm.